⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 4, 2024Open Access

Figure S1 from Circulating miRNA Signature Predicts Cancer Incidence in Lynch Syndrome—A Pilot Study

Tero Sievänen Tiina Jokela Matti Hyvärinen Tia‐Marje Korhonen Kirsi Pylvänäinen Jukka‐Pekka Mecklin Juha Karvanen Elina Sillanpää Toni T. Seppälä Eija K. Laakkonen

View Full Paper

Ask AI

Bookmark

Share

Abstract

Figure S1: Schoenfeld residuals of the c-miR risk prediction models. A, Unadjusted c-miR risk sum score prediction model. B, Sex and MMR-variant adjusted c-miR risk sum score prediction model.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sievänen et al. (2024) studied this question.

synapsesocial.com/papers/68e664bab6db6435875f1402 https://doi.org/10.1158/1940-6207.25964427.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S5 from Circulating miRNA Signature Predicts Cancer Incidence in Lynch Syndrome—A Pilot Study2024
2Table S11 from Circulating miRNA Signature Predicts Cancer Incidence in Lynch Syndrome—A Pilot Study2024
3Table S11 from Circulating miRNA Signature Predicts Cancer Incidence in Lynch Syndrome—A Pilot Study2024
4Table S10 from Circulating miRNA Signature Predicts Cancer Incidence in Lynch Syndrome—A Pilot Study2024
5Table S10 from Circulating miRNA Signature Predicts Cancer Incidence in Lynch Syndrome—A Pilot Study2024